Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 86 of 10364 for:    strength

Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With Hemophilia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03842605
Recruitment Status : Completed
First Posted : February 15, 2019
Last Update Posted : February 15, 2019
Sponsor:
Information provided by (Responsible Party):
David Oleson, Oregon Health and Science University

Brief Summary:

This is a research study of adults with hemophilia that have limitations in elbow joint motion that is the result of bleeding into the joint.

People with hemophilia who have bleeding into their elbow joint may have limitations in elbow joint movement and pain in the joint. This research is being done to determine the effect a strength training program has on the amount of movement people with hemophilia and elbow joint disease have.


Condition or disease Intervention/treatment Phase
Hemophilia Elbow Joint Contracture Other: Strength training Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With Hemophilia
Study Start Date : October 2012
Actual Primary Completion Date : February 2019
Actual Study Completion Date : February 13, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Strength training Other: Strength training



Primary Outcome Measures :
  1. Elbow range of motion [ Time Frame: measurements to be taken at 4 and 8 weeks after entering study ]
    measurement of change of range of motion over time frame



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients of the Oregon health and Science University Hemophilia treatment Center
  • greater or equal to 18 years old
  • Loss of elbow range of motion that is greater than or equal to 5 degrees

Exclusion Criteria:

  • Present inhibitor

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03842605


Locations
Layout table for location information
United States, Oregon
Oregon Health and Science University
Portland, Oregon, United States, 97239-3098
Sponsors and Collaborators
Oregon Health and Science University

Layout table for additonal information
Responsible Party: David Oleson, Associate Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier: NCT03842605     History of Changes
Other Study ID Numbers: 09062
First Posted: February 15, 2019    Key Record Dates
Last Update Posted: February 15, 2019
Last Verified: February 2019
Additional relevant MeSH terms:
Layout table for MeSH terms
Contracture
Hemophilia A
Blood Coagulation Disorders, Inherited
Blood Coagulation Disorders
Hematologic Diseases
Coagulation Protein Disorders
Hemorrhagic Disorders
Genetic Diseases, Inborn
Joint Diseases
Musculoskeletal Diseases
Muscular Diseases